{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:34:46Z","timestamp":1764603286021},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1097\/iio.0000000000000043","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T11:59:34Z","timestamp":1409227174000},"page":"57-70","source":"Crossref","is-referenced-by-count":1,"title":["Medical Management of Exfoliative Glaucoma"],"prefix":"10.1097","volume":"54","author":[{"given":"Mohammed","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ritch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210126","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00061198-199400320-00018","article-title":"Exfoliation syndromethe most common identifiable cause of open-angle glaucoma.","volume":"3","author":"Ritch","year":"1994","journal-title":"J Glaucoma"},{"key":"R2-6-20210126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(00)00196-X","article-title":"Exfoliation syndrome.","volume":"45","author":"Ritch","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0161-6420(86)33664-9","article-title":"Clinical signs of the pseudoexfoliation syndrome.","volume":"93","author":"Prince","year":"1986","journal-title":"Ophthalmology"},{"key":"R4-6-20210126","first-page":"253","article-title":"Why is glaucoma associated with exfoliation syndrome Prog Retin Eye Res.","volume":"22","author":"Ritch","year":"2003","journal-title":""},{"key":"R5-6-20210126","first-page":"1750","article-title":"Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study.","volume":"36","author":"Schlotzer-Schrehardt","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-6-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(03)00077-1","article-title":". Plasma homocysteine is elevated in patients with exfoliation syndrome.","volume":"136","author":"Vessani","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R7-6-20210126","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.2353\/ajpath.2010.090914","article-title":". Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndromeglaucoma.","volume":"176","author":"Zenkel","year":"2010","journal-title":"Am J Pathol"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00417-008-0871-y","article-title":". Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma.","volume":"246","author":"Koliakos","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaophthalmol.2014.100","article-title":". A prospective study of folate, vitamin b6, and vitamin B12 intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma.","volume":"132","author":"Kang","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0014-4835(89)90011-0","article-title":". Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.","volume":"48","author":"Nilsson","year":"1989","journal-title":"Exp Eye Res"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bjo.2006.106690","article-title":". Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.","volume":"91","author":"Konstas","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R12-6-20210126","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ophtha.2006.07.064","article-title":". Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients.","volume":"114","author":"Konstas","year":"2007","journal-title":"Ophthalmology"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archopht.122.1.29","article-title":". Factors associated with long-term progression or stability in exfoliation glaucoma.","volume":"122","author":"Konstas","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.eye.6701345","article-title":". Diurnal intraocular pressure reduction with latanoprost 0.005 compared to timolol maleate 0.5 as monotherapy in subjects with exfoliation glaucoma.","volume":"18","author":"Konstas","year":"2004","journal-title":"Eye (Lond)"},{"key":"R15-6-20210126","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2005.07.004","article-title":". Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma.","volume":"82","author":"Konstas","year":"2006","journal-title":"Exp Eye Res"},{"key":"R16-6-20210126","first-page":"303","article-title":"Does hyposecretion of aqueous humor damage the trabecular meshwork J Glaucoma.","volume":"4","author":"Becker","year":"1995","journal-title":""},{"key":"R17-6-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2008.155317","article-title":". Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprosttimolol fixed combination administered in the morning, or evening in exfoliative glaucoma.","volume":"94","author":"Konstas","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/eye.2010.100","article-title":". 24-h Intraocular pressure control with evening-dosed travoprosttimolol, compared with latanoprosttimolol, fixed combinations in exfoliative glaucoma.","volume":"24","author":"Konstas","year":"2010","journal-title":"Eye (Lond)"},{"key":"R19-6-20210126","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bjophthalmol-2012-302843","article-title":". 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.","volume":"97","author":"Konstas","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1167\/iovs.04-0915","article-title":". Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma.","volume":"46","author":"Schlotzer-Schrehardt","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-6-20210126","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1016\/j.bmcl.2004.04.099","article-title":". Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma.","volume":"14","author":"Okamura","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"R23-6-20210126","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.124.6.793","article-title":". Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.","volume":"124","author":"Barkana","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R25-6-20210126","first-page":"47","article-title":"Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey.","volume":"16","author":"Kaufman","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-6-20210126","first-page":"492","article-title":"Effects of intracameral Na2EDTA and EGTA on aqueous outflow routes in the monkey eye.","volume":"19","author":"Bill","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-6-20210126","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archopht.116.5.633","article-title":". H-7 disrupts the actin cytoskeleton and increases outflow facility.","volume":"116","author":"Tian","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R28-6-20210126","first-page":"239","article-title":". H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys.","volume":"40","author":"Tian","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-6-20210126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/exer.1999.0797","article-title":". Effect of latrunculin-B on outflow facility in monkeys.","volume":"70","author":"Peterson","year":"2000","journal-title":"Exp Eye Res"},{"key":"R30-6-20210126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/02713680600672185","article-title":". Effect of H-7 and Lat-B on retinal physiology.","volume":"31","author":"Kiland","year":"2006","journal-title":"Curr Eye Res"},{"key":"R31-6-20210126","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archopht.122.10.1482","article-title":"Effect of low-dose latrunculin B on anterior segment physiologic features in the monkey eye.","volume":"122","author":"Okka","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R32-6-20210126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.exer.2005.06.017","article-title":". Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys.","volume":"82","author":"Sabanay","year":"2006","journal-title":"Exp Eye Res"},{"key":"R33-6-20210126","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1167\/iovs.05-0327","article-title":"Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes.","volume":"47","author":"Ethier","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-6-20210126","first-page":"1029","article-title":". Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.","volume":"42","author":"Rao","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R36-6-20210126","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/40187","article-title":". Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"key":"R38-6-20210126","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ajo.2013.05.016","article-title":". K-115 Clinical Study Group. Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension.","volume":"156","author":"Tanihara","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R42-6-20210126","first-page":"3016","article-title":"Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells.","volume":"43","author":"Shearer","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R44-6-20210126","doi-asserted-by":"crossref","first-page":"1726S","DOI":"10.1093\/jn\/136.6.1726S","article-title":"The many facets of hyperhomocysteinemia: studies from the Framingham cohorts.","volume":"136suppl","author":"Selhub","year":"2006","journal-title":"J Nutr"},{"key":"R45-6-20210126","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/01902140600611629","article-title":"Elastin defects in the lungs of avian and murine models of homocysteinemia.","volume":"31","author":"Starcher","year":"2005","journal-title":"Exp Lung Res"},{"key":"R46-6-20210126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00061198-200302000-00007","article-title":". Hyperhomocystinemia in pseudoexfoliation glaucoma.","volume":"12","author":"Leibovitch","year":"2003","journal-title":"J Glaucoma"},{"key":"R47-6-20210126","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2004.02.027","article-title":". Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma.","volume":"138","author":"Bleich","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R48-6-20210126","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00417-004-0918-7","article-title":". Plasma and aqueous humour levels of homocysteine in exfoliation syndrome.","volume":"242","author":"Puustjarvi","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R49-6-20210126","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00417-004-1097-2","article-title":". Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.","volume":"243","author":"Altintas","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R50-6-20210126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00417-010-1487-6","article-title":". Levels of plasma homocysteine in pseudoexfoliation glaucoma.","volume":"249","author":"Tranchina","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R51-6-20210126","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/IJG.0b013e31802d6942","article-title":". Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma.","volume":"16","author":"Roedl","year":"2007","journal-title":"J Glaucoma"},{"key":"R52-6-20210126","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1373\/clinchem.2006.083881","article-title":". Homocysteine, 5,10-methylenetetrahydrofolate reductase 677CT polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.","volume":"53","author":"Zee","year":"2007","journal-title":"Clin Chem"},{"key":"R53-6-20210126","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0002-9149(98)01041-8","article-title":". Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12.","volume":"83","author":"Lobo","year":"1999","journal-title":"Am J Cardiol"},{"key":"R54-6-20210126","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00702-006-0598-z","article-title":". Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma.","volume":"114","author":"Roedl","year":"2007","journal-title":"J Neural Transm"},{"key":"R55-6-20210126","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jnutbio.2006.11.002","article-title":"Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix.","volume":"18","author":"Katula","year":"2007","journal-title":"J Nutr Biochem"},{"key":"R56-6-20210126","first-page":"2952","article-title":"Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton.","volume":"58","author":"Lewis","year":"1998","journal-title":"Cancer Res"},{"key":"R57-6-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00335510500429821","article-title":". Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects.","volume":"66","author":"Holven","year":"2006","journal-title":"Scand J Clin Lab Invest"},{"key":"R58-6-20210126","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ajo.2006.01.047","article-title":"Ocular and systemic pseudoexfoliation syndrome.","volume":"141","author":"Schlotzer-Schrehardt","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R59-6-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2298\/VSP1203231D","article-title":". Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucomasyndrome.","volume":"69","author":"Djordjevic-Jocic","year":"2012","journal-title":"Vojnosanit Pregl"},{"key":"R60-6-20210126","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1167\/iovs.13-12941","article-title":". Clusterin and complement activation in exfoliation glaucoma.","volume":"55","author":"Doudevski","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R61-6-20210126","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.1146554","article-title":". Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.","volume":"317","author":"Thorleifsson","year":"2007","journal-title":"Science"},{"key":"R62-6-20210126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exer.2009.05.001","article-title":"1, Chataway T, Burdon KP, et al.. Identification of LOXL1 protein and apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.","volume":"89","author":"Sharma","year":"2009","journal-title":"Exp Eye Res"},{"key":"R63-6-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2004.06.015","article-title":". High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells.","volume":"177","author":"Raposo","year":"2004","journal-title":"Atherosclerosis"},{"key":"R64-6-20210126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.matbio.2007.02.003","article-title":"Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects.","volume":"26","author":"Oleggini","year":"2007","journal-title":"Matrix Biol"},{"key":"R65-6-20210126","first-page":"S278","article-title":". Role of transforming growth factor- and its latent form binding protein in pseudoexfoliation syndrome.","volume":"40","author":"Schlotzer-Schrehardt","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R66-6-20210126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1026557029227","article-title":". Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion.","volume":"23","author":"Saatci","year":"1999","journal-title":"Int Ophthalmol"},{"key":"R67-6-20210126","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1034\/j.1600-0420.2001.790509.x","article-title":". Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. A histopathologic and electron micrographic study.","volume":"79","author":"Cursiefen","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"R68-6-20210126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-3768.2009.01578.x","article-title":". Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis.","volume":"88","author":"Ritch","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R69-6-20210126","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/eye.2009.152","article-title":". Retinal vascular occlusions occur more frequently in the more affected eye in exfoliation syndrome.","volume":"24","author":"Prata","year":"2010","journal-title":"Eye (Lond)"},{"key":"R71-6-20210126","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archopht.119.7.1023","article-title":"Unilateral or asymmetric pseudoexfoliation syndrome An ultrastructural study.","volume":"119","author":"Hammer","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R72-6-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0002-9394(99)00255-X","article-title":"Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation.","volume":"129","author":"Shrum","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R73-6-20210126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/030006059001800411","article-title":". Short- and long-term effect of nifedipine on the visual field in patients with presumed vasospasm.","volume":"18","author":"Gasser","year":"1990","journal-title":"J Int Med Res"},{"key":"R74-6-20210126","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/BF02172889","article-title":"The effect of calcium antagonist on visual field in low-tension glaucoma.","volume":"227","author":"Kitazawa","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R75-6-20210126","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/bjo.56.6.447","article-title":"Systemic blood pressure in open-angle, low-tension glaucoma, and the normal eye.","volume":"52","author":"Leighton","year":"1972","journal-title":"Br J Ophthalmol"},{"key":"R76-6-20210126","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.ophtha.2008.05.015","article-title":". A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.","volume":"115","author":"Koseki","year":"2008","journal-title":"Ophthalmology"},{"key":"R77-6-20210126","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0940-2993(01)80017-8","article-title":". The influence of hypoxia on the myocardium of experimentally diabetic rats with and without Ginkgo biloba extract.","volume":"52","author":"Fitzl","year":"2001","journal-title":"Exp Toxicol Pathol"},{"key":"R78-6-20210126","first-page":"685","article-title":". GBE EGb 761 protects against mitochondrial aging in the brain and in the liver.","volume":"48","author":"Sastre","year":"2002","journal-title":"Cell Mol Biol"},{"key":"R79-6-20210126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0014-2999(98)00903-0","article-title":"Inhibition of serum deprivation- and staurosporine-imduced neuronal apoptosis by Ginkgo biloba extract and some of its constituents.","volume":"367","author":"Ahlemeyer","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R80-6-20210126","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.1997.03550160047037","article-title":". A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia.","volume":"278","author":"Le Bars","year":"1997","journal-title":"JAMA"},{"key":"R81-6-20210126","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.bmc.2005.03.035","article-title":". Anti-oxidant activities of curcumin and related enones.","volume":"13","author":"Weber","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"R82-6-20210126","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jnr.20610","article-title":". Neuroprotective mechanisms of curcumin against cerebral ischemia induced neuronal apoptosis and behavioral deficits.","volume":"82","author":"Wang","year":"2005","journal-title":"J Neurosci Res"},{"key":"R83-6-20210126","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":". Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinsons disease.","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free Radic Res"},{"key":"R84-6-20210126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s004170050261","article-title":". Optic disc changes in normotensive persons with unilateral exfoliation syndrome: a 3-year follow-up study.","volume":"237","author":"Puska","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R85-6-20210126","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.ophtha.2012.03.015","article-title":". LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.","volume":"119","author":"Schlotzer-Schrehardt","year":"2012","journal-title":"Ophthalmology"},{"key":"R87-6-20210126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coph.2012.10.003","article-title":". Nanomedicine for the treatment of retinal and optic nerve diseases.","volume":"13","author":"Zarbin","year":"2013","journal-title":"Curr Opin Pharmacol"}],"container-title":["International Ophthalmology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IIO.0000000000000043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:04:00Z","timestamp":1621886640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004397-201405440-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iio.0000000000000043","relation":{},"ISSN":["0020-8167"],"issn-type":[{"value":"0020-8167","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}